Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2525897123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Xu He und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100191, People's Republic of China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Membrane Proteins, Polymers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: | Natural Science Foundation of Beijing Municipality (), MOST | National Natural Science Foundation of China (NSFC), Postdoctoral Fellowship Program of CPSF.
Abstract (Originalsprache)
Inhibiting stimulator of interferon genes (STING) is critical for treating rheumatoid arthritis (RA), yet achieving precise suppression with high tissue specificity across protein variants remains challenging. Here, we engineer a multilevel, intelligent STING degrader—charge-reversal proteolysis-targeting chimeras (CreTACs)—that efficiently delivers to RA sites and degrades STING variants in humans, mice, and rats. Unlike traditional degraders with systemic toxicity, this charge reversal platform leverages pH-programmed charge inversion: Electroneutrality in circulation (pH 7.4) minimizes toxicity, while acidic-triggered protonation enables a 7.5-fold increase in arthritic joint accumulation (tissue level), pH-gated cellular internalization (80% uptake at pH 6.5 vs. 50% at pH 7.4; cellular level), and enhanced cytoplasmic STING (proton channel) affinity via charge interactions (protein level). In collagen-induced arthritis models, CreTACs outperformed methotrexate by suppressing synovitis and bone erosion without hematological toxicity. This multilevel charge reversal strategy establishes a blueprint for next-generation proteolysis drug-delivery systems or biomaterials, offering transformative potential for healthcare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, Peking University First Hospital, Beijing 100191, People's Republic of China.
- Department of Pharmacy, Peking University People's Hospital, Beijing 100044, People's Republic of China.
- Institute of Systems Biomedicine, School of Basic Medical Sciences, Beijing Key Laboratory of Tumor Systems Biology, Peking University Health Science Center, Beijing 100191, People's Republic of China.
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center, Beijing 100191, People's Republic of China.
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing 100044, People's Republic of China.
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100190, People's Republic of China.
ORCID-Profile: Xu He, Wei Wei, Zhiqiang Lin
Förderung
- | Natural Science Foundation of Beijing Municipality ()
- MOST | National Natural Science Foundation of China (NSFC)
- Postdoctoral Fellowship Program of CPSF
- Peking University People's Hospital Research and Development Funds
- Young Scientists Fund of Natural Science Foundation of Beijing
- National Natural Science Foundation of China Youth Program
- 北京市科学技术委员会 | Natural Science Foundation of Beijing Municipality
- Peking University People’s Hospital Research and Development Funds
Zitieren
APA
He, X., Gong, L., Zhang, J., Pang, X., Li, Y., Wei, W., Cui, Y., & Lin, Z. (2026). Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2525897123
Vancouver
He X, Gong L, Zhang J, Pang X, Li Y, Wei W, et al. Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2525897123
BibTeX
@article{He2026,
author = {He, Xu and Gong, Lidong and Zhang, Juqi and Pang, Xiaocong and Li, Yuhui and Wei, Wei and Cui, Yimin and Lin, Zhiqiang},
title = {Charge-reversal proteolysis polymers enable tissue-specific STING degradation in rheumatoid arthritis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2525897123}
}
EUVIMED